Showing results (41-50 of 78) with videos related to

Sort By:
Pageof 8
Cancer Research|February 3, 2006
The anti-human leukocyte antigen-DR monoclonal antibody 1D09C3 activates the mitochondrial cell death pathway and exerts a potent antitumor activity in lymphoma-bearing nonobese diabetic/severe combined immunodeficient miceCarmelo Carlo-Stella, Massimo Di Nicola, Maria Caterina Turco, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 13, 2006
Rituximab induces effective clearance of minimal residual disease in molecular relapses of mantle cell lymphomaMarco Ladetto, Michele Magni, Gloria Pagliano, et al.
Blood|January 16, 2010
Human CD34+ cells engineered to express membrane-bound tumor necrosis factor-related apoptosis-inducing ligand target both tumor cells and tumor vasculatureCristiana Lavazza, Carmelo Carlo-Stella, Arianna Giacomini, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 26, 2004
Boosting T cell-mediated immunity to tyrosinase by vaccinia virus-transduced, CD34(+)-derived dendritic cell vaccination: a phase I trial in metastatic melanomaMassimo Di Nicola, Carmelo Carlo-Stella, Roberta Mortarini, et al.
Blood|November 25, 2003
Early hematopoietic zinc finger protein (EHZF), the human homolog to mouse Evi3, is highly expressed in primitive human hematopoietic cellsHeather M Bond, Maria Mesuraca, Ennio Carbone, et al.
British Journal of Haematology|July 9, 2002
The modified International Prognostic Index can predict the outcome of localized primary intestinal lymphoma of both extranodal marginal zone B-cell and diffuse large B-cell histologiesSergio Cortelazzo, Andrea Rossi, Elena Oldani, et al.
Cancer|May 14, 2011
Myeloablative doses of yttrium-90-ibritumomab tiuxetan and the risk of secondary myelodysplasia/acute myelogenous leukemiaAnna Guidetti, Carmelo Carlo-Stella, Marco Ruella, et al.
Blood|November 23, 2006
A phase 1/2 trial of arginine butyrate and ganciclovir in patients with Epstein-Barr virus-associated lymphoid malignanciesSusan P Perrine, Olivier Hermine, Trudy Small, et al.
European Journal of Haematology|August 2, 2006
Very high levels of soluble CD30 recognize the patients with classical Hodgkin's lymphoma retaining a very poor prognosisCarlo Visco, Gianpaolo Nadali, Theodoros P Vassilakopoulos, et al.
Clinical Genitourinary Cancer|January 8, 2014
Long-term efficacy and safety outcomes of modified (simplified) MVAC (methotrexate/vinblastine/doxorubicin/cisplatin) as frontline therapy for unresectable or metastatic urothelial cancerAndrea Necchi, Luigi Mariani, Patrizia Giannatempo, et al.
Pageof 8